General Info
Restem Group is a leading clinical-stage biopharmaceutical company focused on the discovery and development of patients.
Location: Corona
Country:
Industries:
Investment Regions:
Investment Stages: late-stage, pre-seed, seed, series-a
Website: https://restem.com/
corporate-vc
Want to start building warm intros with this investor?
🤖 AI Activity Report
Status: active
AI Reasoning: Search of Restem Group press releases and news shows multiple company updates and regulatory designations in 2024 and 2025. The most recent identifiable activity related to investments/funding or corporate updates is a GlobeNewswire corporate update dated January 10, 2025, and subsequent presentations/announcements in June 2025. The most recent external event tied to the company was June 6, 2025 (presentation at EULAR 2025). That event is 4 months and 26 days before the reference date, placing the last known investment/activity between 6 and 3 months ago. The startup mentioned in the press releases is Restem-L/ULSC program.
Here are the thresholds established for the different statuses:
Not Active – No known investments in the last 12 months.
Low Activity – Only known investments between the last 12 and 6 months.
Active – Known investments between the last 6 and 3 months.
Very Active – Known investments in the last 3 months.
Investor Contact
Team Members
Name
Role
Email
LinkedIn
…
…
…
…
…
Investment Regions Map
loading map…
Similar Investors
Other similar investors:
Latest on X (Twitter)
Access all contact details of Restem Group
Gain instant access to partner names, verified emails, LinkedIn profiles, and more—all in one place. Dive into their portfolio founders and their LinkedIn information, so you can quickly start your outreach and look for warm intros.
Add custom tags to your investor cards. Label them by investment stage, industry focus, interest level, or any other criteria you want to stay organized.
Trusted by Founders like You
Find your matching investors using AI